171 related articles for article (PubMed ID: 20147519)
1. A novel role for the viral Rev protein in promoting resistance to superinfection by human immunodeficiency virus type 1.
Levin A; Hayouka Z; Friedler A; Brack-Werner R; Volsky DJ; Loyter A
J Gen Virol; 2010 Jun; 91(Pt 6):1503-13. PubMed ID: 20147519
[TBL] [Abstract][Full Text] [Related]
2. Peptides derived from HIV-1 integrase that bind Rev stimulate viral genome integration.
Levin A; Hayouka Z; Helfer M; Brack-Werner R; Friedler A; Loyter A
PLoS One; 2009; 4(1):e4155. PubMed ID: 19127291
[TBL] [Abstract][Full Text] [Related]
3. Novel regulation of HIV-1 replication and pathogenicity: Rev inhibition of integration.
Levin A; Hayouka Z; Brack-Werner R; Volsky DJ; Friedler A; Loyter A
Protein Eng Des Sel; 2009 Dec; 22(12):753-63. PubMed ID: 19875511
[TBL] [Abstract][Full Text] [Related]
4. Nucleocytoplasmic shuttling of HIV-1 integrase is controlled by the viral Rev protein.
Levin A; Hayouka Z; Friedler A; Loyter A
Nucleus; 2010; 1(2):190-201. PubMed ID: 21326951
[TBL] [Abstract][Full Text] [Related]
5. Integration of HIV-1 DNA is regulated by interplay between viral rev and cellular LEDGF/p75 proteins.
Levin A; Rosenbluh J; Hayouka Z; Friedler A; Loyter A
Mol Med; 2010; 16(1-2):34-44. PubMed ID: 19855849
[TBL] [Abstract][Full Text] [Related]
6. The human immunodeficiency virus type 1 Rev protein: ménage à trois during the early phase of the lentiviral replication cycle.
Grewe B; Überla K
J Gen Virol; 2010 Aug; 91(Pt 8):1893-1897. PubMed ID: 20538907
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of the HIV-1 integrase enzymatic activity and cDNA integration by a peptide derived from the integrase protein.
Levin A; Hayouka Z; Helfer M; Brack-Werner R; Friedler A; Loyter A
Biopolymers; 2010 Aug; 93(8):740-51. PubMed ID: 20517955
[TBL] [Abstract][Full Text] [Related]
8. Interaction between HIV-1 Rev and integrase proteins: a basis for the development of anti-HIV peptides.
Rosenbluh J; Hayouka Z; Loya S; Levin A; Armon-Omer A; Britan E; Hizi A; Kotler M; Friedler A; Loyter A
J Biol Chem; 2007 May; 282(21):15743-53. PubMed ID: 17403681
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human immunodeficiency virus type 1 in human T cells by a potent Rev response element decoy consisting of the 13-nucleotide minimal Rev-binding domain.
Lee SW; Gallardo HF; Gilboa E; Smith C
J Virol; 1994 Dec; 68(12):8254-64. PubMed ID: 7966618
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human immunodeficiency virus Rev and human T-cell leukemia virus Rex function, but not Mason-Pfizer monkey virus constitutive transport element activity, by a mutant human nucleoporin targeted to Crm1.
Bogerd HP; Echarri A; Ross TM; Cullen BR
J Virol; 1998 Nov; 72(11):8627-35. PubMed ID: 9765402
[TBL] [Abstract][Full Text] [Related]
11. LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes.
Llano M; Vanegas M; Fregoso O; Saenz D; Chung S; Peretz M; Poeschla EM
J Virol; 2004 Sep; 78(17):9524-37. PubMed ID: 15308744
[TBL] [Abstract][Full Text] [Related]
12. The RNA helicase DDX1 is involved in restricted HIV-1 Rev function in human astrocytes.
Fang J; Acheampong E; Dave R; Wang F; Mukhtar M; Pomerantz RJ
Virology; 2005 Jun; 336(2):299-307. PubMed ID: 15892970
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a replication-defective human immunodeficiency virus type 1 att site mutant that is blocked after the 3' processing step of retroviral integration.
Chen H; Engelman A
J Virol; 2000 Sep; 74(17):8188-93. PubMed ID: 10933731
[TBL] [Abstract][Full Text] [Related]
14. Intracellular immunization against HIV-1 infection of human T lymphocytes: utility of anti-rev single-chain variable fragments.
Duan L; Zhu M; Bagasra O; Pomerantz RJ
Hum Gene Ther; 1995 Dec; 6(12):1561-73. PubMed ID: 8664381
[TBL] [Abstract][Full Text] [Related]
15. Expression of Nef from unintegrated HIV-1 DNA downregulates cell surface CXCR4 and CCR5 on T-lymphocytes.
Sloan RD; Donahue DA; Kuhl BD; Bar-Magen T; Wainberg MA
Retrovirology; 2010 May; 7():44. PubMed ID: 20465832
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 latency due to the site of proviral integration.
Winslow BJ; Pomerantz RJ; Bagasra O; Trono D
Virology; 1993 Oct; 196(2):849-54. PubMed ID: 8372452
[TBL] [Abstract][Full Text] [Related]
17. Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function.
Neumann M; Felber BK; Kleinschmidt A; Froese B; Erfle V; Pavlakis GN; Brack-Werner R
J Virol; 1995 Apr; 69(4):2159-67. PubMed ID: 7884864
[TBL] [Abstract][Full Text] [Related]
18. The carboxy-terminal region of the human immunodeficiency virus type 1 protein Rev has multiple roles in mediating CRM1-related Rev functions.
Hakata Y; Yamada M; Mabuchi N; Shida H
J Virol; 2002 Aug; 76(16):8079-89. PubMed ID: 12134013
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 (HIV-1) Vpr enhances expression from unintegrated HIV-1 DNA.
Poon B; Chen IS
J Virol; 2003 Apr; 77(7):3962-72. PubMed ID: 12634356
[TBL] [Abstract][Full Text] [Related]
20. Retroviral superinfection resistance.
Nethe M; Berkhout B; van der Kuyl AC
Retrovirology; 2005 Aug; 2():52. PubMed ID: 16107223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
